Literature DB >> 16809101

Involvement of cell junctions in hepatocyte culture functionality.

Mathieu Vinken1, Peggy Papeleu, Sarah Snykers, Evelien De Rop, Tom Henkens, James Kevin Chipman, Vera Rogiers, Tamara Vanhaecke.   

Abstract

In liver, like in other multicellular systems, the establishment of cellular contacts is a prerequisite for normal functioning. In particular, well-defined cell junctions between hepatocytes, including adherens junctions, desmosomes, tight junctions, and gap junctions, are known to play key roles in the performance of liver-specific functionality. In a first part of this review article, we summarize the current knowledge concerning cell junctions and their roles in hepatic (patho)physiology. In a second part, we discuss their relevance in liver-based in vitro modeling, thereby highlighting the use of primary hepatocyte cultures as suitable in vitro models for preclinical pharmaco-toxicological testing. We further describe the actual strategies to regain and maintain cell junctions in these in vitro systems over the long-term.

Mesh:

Year:  2006        PMID: 16809101     DOI: 10.1080/10408440600599273

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  33 in total

1.  Role of connexin-related signalling in hepatic homeostasis and its relevance for liver-based in vitro modelling.

Authors:  Mathieu Vinken
Journal:  World J Gastrointest Pathophysiol       Date:  2011-10-15

Review 2.  Mesenchymal stromal cells as supportive cells for hepatocytes.

Authors:  Alejandro Gómez-Aristizábal; Armand Keating; John E Davies
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

Review 3.  Modulation of connexin signaling by bacterial pathogens and their toxins.

Authors:  Liesbeth Ceelen; Freddy Haesebrouck; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Cell Mol Life Sci       Date:  2011-06-09       Impact factor: 9.261

4.  Advancements in in vitro hepatic models: application for drug screening and therapeutics.

Authors:  Apeksha Damania; Era Jain; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-05       Impact factor: 6.047

5.  Long-term culture of primary hepatocytes: new matrices and microfluidic devices.

Authors:  Britta Burkhardt; Juan José Martinez-Sanchez; Anastasia Bachmann; Ruth Ladurner; Andreas K Nüssler
Journal:  Hepatol Int       Date:  2013-11-21       Impact factor: 6.047

Review 6.  Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.

Authors:  Chen Chen; Alejandro Soto-Gutierrez; Pedro M Baptista; Bart Spee
Journal:  Gastroenterology       Date:  2018-02-08       Impact factor: 22.682

Review 7.  Cell sources for in vitro human liver cell culture models.

Authors:  Katrin Zeilinger; Nora Freyer; Georg Damm; Daniel Seehofer; Fanny Knöspel
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-05

8.  Biotunable acoustic node assembly of organoids.

Authors:  Pu Chen; Sinan Güven; Osman Berk Usta; Martin L Yarmush; Utkan Demirci
Journal:  Adv Healthc Mater       Date:  2015-07-07       Impact factor: 9.933

9.  Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway.

Authors:  Dong Fu; Yoshiyuki Wakabayashi; Jennifer Lippincott-Schwartz; Irwin M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

10.  The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation.

Authors:  Kuo Du; C David Williams; Mitchell R McGill; Yuchao Xie; Anwar Farhood; Mathieu Vinken; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-09-23       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.